Skip to content

Clinical trials

Completed Autoimmune Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Status: Completed Clear all

343 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20025
200311
20044
200511
20068
20078
200811
200912
201016
201118
201217
201321
201411
201512
201613
201717
201823
201910
202018
202123
202214
202320
20249
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed343

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline13
National Institute of Allergy and Infectious Diseases (NIAID)11
National Heart, Lung, and Blood Institute (NHLBI)10
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)8
Human Genome Sciences Inc., a GSK Company7
Assistance Publique - Hôpitaux de Paris6
National Institute of Dental and Craniofacial Research (NIDCR)5
National Institute of Environmental Health Sciences (NIEHS)5
Amgen4
National Cancer Institute (NCI)4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases343
Immune System Diseases48
Lupus Erythematosus, Systemic42
Arthritis, Rheumatoid39
Multiple Sclerosis33
Diabetes Mellitus, Type 131
Diabetes Mellitus24
Endocrine System Diseases20
Connective Tissue Diseases17
Rheumatic Diseases16

Trials

Showing 1 to 25 of 343. Each trial links to its page on Pharma Observatory.

243 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.